Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs
暂无分享,去创建一个
O. Nerman | B. Skoog | F. Piehl | J. Hillert | J. Fagius | A. Landtblom | C. Dahle | S. Fredrikson | O. Andersen | L. Stawiarz | J. Lycke | B. Runmarker | M. Vrethem | V. Lisovskaja | H. Tedeholm | S. Fredrikson | C. Malmeström | C. Martín | V. Lisovskaja